Effects on Growth of Smell and Taste of Milk During Tube Feeding of Preterm Infants: A Randomized Clinical Trial.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 11 2021
Historique:
pubmed: 10 8 2021
medline: 27 1 2022
entrez: 9 8 2021
Statut: ppublish

Résumé

Smell and taste of food increase food anticipation, activate gut motility, and stimulate digestion and metabolism. Despite poor growth of many preterm infants in neonatal intensive care units, the smell and taste of milk with tube feeding are not generally considered a regular component of care. To determine the effect of smell and taste of milk with tube feeding on weight z scores at discharge from the hospital. A randomized, controlled, nonblinded, superiority trial was conducted at 2 perinatal centers between May 9, 2017, and February 1, 2020. Eligible infants (n = 659) were born at less than 29 weeks' postmenstrual age (PMA) and/or with a birth weight of less than 1250 g. Infants were randomly assigned to receive either the smell and taste of milk with each tube feeding or routine care without the provision of smell and taste of milk. The primary outcome was weight z score at discharge from any hospital. Secondary outcomes included anthropometric measures at predefined time points, time to full enteral feeds, and other health outcomes associated with prematurity. Of the 658 infants, a total of 396 infants were randomized; some parents had not been approached for consent (n = 144) or declined participation (n = 117), and 1 infant with consent was not randomized. Of the 396 infants, 196 were assigned to the treatment group (51% male; mean [SD] PMA at birth, 27.5 [2.2] weeks) and 200 were assigned to the control group (52% male; mean [SD] PMA at birth, 27.6 (2.3) weeks). Mean weight z scores at discharge were -0.87 (95% CI, -1.02 to -0.72) for the treatment group and -0.97 (95% CI, -1.11 to -0.83) for the control group (P = .40). The mean difference in z scores between the treatment and control groups at 36 weeks' PMA was 0.21 (95% CI, 0.01 to 0.4; P = .04) for head circumference and 0.26 (95% CI, 0.05 to 0.51; P = .04) for length. There were no clinically notable differences between the study groups for any other anthropometric, feeding, or health outcomes. In this randomized clinical trial, regular smell and taste of milk included with tube feeding did not improve weight at discharge in preterm infants. Secondary outcomes suggest exposure to smell and taste may improve head circumference and length at 36 weeks' PMA, but not at discharge. Regular exposure to the smell and taste of milk is a simple and inexpensive intervention with potential benefits and no apparent adverse effects. anzctr.org.au Identifier: ACTRN12617000583347.

Identifiants

pubmed: 34369975
pii: 2782797
doi: 10.1001/jamapediatrics.2021.2336
pmc: PMC8353575
doi:

Banques de données

ANZCTR
['ACTRN12617000583347']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1115-1123

Auteurs

Friederike Beker (F)

Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.
Neonatal Critical Care Unit, Mater Health, South Brisbane, Queensland, Australia.

Helen G Liley (HG)

Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.
Neonatal Critical Care Unit, Mater Health, South Brisbane, Queensland, Australia.

Ian P Hughes (IP)

Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.
Office for Research Governance and Development, Gold Coast University Hospital, Southport, Queensland, Australia.

Susan E Jacobs (SE)

Neonatal Services and Newborn Research, the Royal Women's Hospital, Melbourne, Victoria, Australia.
Clinical Sciences Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Obstetrics and Gynaecology, University of Melbourne, the Royal Women's Hospital, Melbourne, Victoria, Australia.

Judith Macey (J)

Mater Research Institute, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.

Emily Twitchell (E)

Neonatal Services and Newborn Research, the Royal Women's Hospital, Melbourne, Victoria, Australia.

Peter G Davis (PG)

Neonatal Services and Newborn Research, the Royal Women's Hospital, Melbourne, Victoria, Australia.
Clinical Sciences Research, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Obstetrics and Gynaecology, University of Melbourne, the Royal Women's Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH